ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0341

Patient Perspectives on the Usability of a Rheumatoid Arthritis Patient-reported Outcomes Electronic Health Record-based Dashboard: A Mixed-Methods Study

Cherish Wilson1, Catherine Nasrallah2, Alicia Hamblin2, Lindsay Jacobsohn2, Cammie Young3, Cammie Young3, Mary Nakamura4, Andrew Gross2, Judith Ashouri2, Brett Dietz2, Mehrdad Matloubian2, Jinoos Yazdany5 and Gabriela Schmajuk1, 1UCSF / SFVA, San Francisco, CA, 2University of California San Francisco, San Francisco, CA, 3University of California San Francisco, Oakland, CA, 4UCSF/SFVAHCS, San Francisco, CA, 5University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA

Meeting: ACR Convergence 2023

Keywords: informatics, Patient reported outcomes, quality of care, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0325–0344) Patient Outcomes, Preferences, & Attitudes Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Shared decision making, health literacy, and effective communication around patient-reported outcomes (PROs) are vital components to a treat-to-target approach in rheumatoid arthritis (RA) patients. To enhance these areas of patient care, we developed an EHR-integrated, patient-facing sidecar dashboard application that displays RA outcomes (disease activity, functional status, pain scores), medications, and lab results for use during clinical visits (Figure). The dashboard was rolled out at an academic rheumatology clinic as part of a stepped-wedge pragmatic randomized trial starting in 2021. This study aimed to assess patient perspectives on the usability of the dashboard using a mixed-methods approach.

Methods: Consecutive RA patients whose clinicians used the dashboard during a visit were invited to complete a survey regarding the usability of the dashboard. Using purposive sampling to ensure that a range of usability perspectives were included, a subset of patients was invited to participate in semi-structured interviews to assess their perceptions of the dashboard. Recorded interviews were transcribed verbatim and thematically analyzed using inductive and deductive techniques.

Results: 181 patients responded to the survey. Most patients (79%) were interested in seeing the dashboard again at a future visit and felt that the dashboard helped them talk to their physician about their RA symptoms (76%) and medications (71%; Table 1). Many also reported that the dashboard helped them understand more about their disease (71%) and make better decisions about their RA care (67%).

Similar themes emerged from the qualitative interviews (N = 27; 89% women, mean age 57 years, 74% with self-reported high health literacy; see Table 2). Perceived benefits of the dashboard included visualizing disease progression and changes over time, which engaged patients in their care and increased their motivation to control their disease. Patients valued how the dashboard allowed physicians to conveniently access their RA outcome information. On the interpersonal level, patients noted improved communication around goals of care (disease progression and treatment), and increased trust and confidence in their providers. Despite being comfortable with technology, patients also identified some challenges, including that they found it difficult to understand RA outcomes or the dashboard content without some explanation from physicians. Patients also expressed a wish to access the dashboard in-between visits.

Conclusion: In this mixed-methods study, most patients felt that a sidecar dashboard application enhanced their clinical encounters. Positive feedback from patients suggests that routine use of the dashboard has potential to improve patient engagement in RA care. Patients also suggested specific areas for improvement in accessibility, design, and content, which should be considered to further optimize the dashboard.

Supporting image 1

Figure. Screenshot of the rheumatoid arthritis patient-facing sidecar dashboard application, which incorporated historical and real-time EHR data to display trajectories of RA outcomes.Table 1. Selected patient survey questions examining usability of the RA dashboard (N = 181).

Supporting image 2

Table 1. Selected patient survey questions examining usability of the RA dashboard (N = 181).

Supporting image 3

Table 2. Patients’ perceptions about the dashboard: Results of qualitative interviews.


Disclosures: C. Wilson: None; C. Nasrallah: None; A. Hamblin: None; L. Jacobsohn: None; C. Young: None; C. Young: None; M. Nakamura: None; A. Gross: None; J. Ashouri: None; B. Dietz: None; M. Matloubian: None; J. Yazdany: AstraZeneca, 2, 5, Aurinia, 5, Gilead, 5, Pfizer, 2; G. Schmajuk: None.

To cite this abstract in AMA style:

Wilson C, Nasrallah C, Hamblin A, Jacobsohn L, Young C, Young C, Nakamura M, Gross A, Ashouri J, Dietz B, Matloubian M, Yazdany J, Schmajuk G. Patient Perspectives on the Usability of a Rheumatoid Arthritis Patient-reported Outcomes Electronic Health Record-based Dashboard: A Mixed-Methods Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/patient-perspectives-on-the-usability-of-a-rheumatoid-arthritis-patient-reported-outcomes-electronic-health-record-based-dashboard-a-mixed-methods-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-perspectives-on-the-usability-of-a-rheumatoid-arthritis-patient-reported-outcomes-electronic-health-record-based-dashboard-a-mixed-methods-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology